Orgenesis Inc

Market cap: $28,689,357

Exchange: NAS

Sector: Health Technology

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Point-Of-Care Cell Therapy (POC) segments. The CDMO segment through MaSTherCell, comprises of services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The POC segment provides multitude of cell therapies including, but not limited to, cell-based immunotherapies, therapeutics for metabolic diseases, neurodegenerative diseases and tissue regeneration. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.

Key Statistics

Company Name

Orgenesis Inc

Average Volume (10 days)

51,214

Average Volume (30 days)

106,716

Moving Average (50 days)

$0.5883

Moving Average (200 days)

$0.5865

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

28,689,357

Shares Outstanding

31,877,063

52-Week High Split Adjust Only

1.5

52-Week Low Split Adjust Only

0.25

Employee Count

72

Beta

1.0328

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.01%

Past 30 days

1.2%

Past 3 months

1%

Past 6 months

0.53%

Past year

-0.35%

Past 2 years

-0.72%

Past 5 years

-0.82%

Max % Change

7.18%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Orgenesis IncORGSn/an/a-7.1n/an/a
Peer AvgN/A0.781.305.50.780.88
Premier Inc - Class APINC2.551.8213.52.552.86
Patterson Companies Inc.PDCO0.563.3715.50.560.65
Orgenesis IncORGSn/an/a-7.1n/an/a
PetVivo Holdings IncPETVn/an/an/an/an/a